Gastrointestinal permeability - A parameter of possible prognostic importance in metastatic colorectal carcinoma

Pteridines

Volumn 19, Issue 1, 2008, Pages 19-22

  Melichar, Bohuslav ^a,b   Hyspler, Radomír ^a   Kalabova, Hana ^a   Urbanek, Lubor ^a   Krcmova, Lenka ^a   Solichova, Dagmar ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Colorectal carcinoma; Intestinal permeability; Neopterin

Indexed keywords

CETUXIMAB; CREATININE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LACTULOSE; MANNITOL; NEOPTERIN; OXALIPLATIN; SUCRALOSE; SUCROSE; XYLOSE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CAPILLARY GAS CHROMATOGRAPHY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GLUCOSE URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE MUCOSA PERMEABILITY; LOADING DRUG DOSE; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; URINE LEVEL;

EID: 44949222520     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.2008.19.1.19     Document Type: Article

References (9)

1. Melichar B, Dvorak J, Hyspler R, Zadak Z. Intestinal permeability in the assessment of intestinal toxicity of cytotoxic agents. Chemotherapy 2005; 51: 336-338.
2. Melichar B, Hyspler R, Dragounova E. Intestinal permeability - a prognostic indicator in ovarian cancer? J Clin Gastroenterol 2008; in press.
3. Melichar B, Urbanek L, Krcmova L, et al. Urinary neopterin in patients with ovarian cancer. Pteridines 2006; 17: 145-153.
4. Melichar B, Solichová D, Freedman RS. Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies. Int J Gynecol Cancer 2006; 16: 240-252.
5. Melichar B, Solichova D, Melicharova K, Malirova E, Cermanova M, Zadak Z. Urinary neopterin in patients with advanced colorectal carcinoma. Int J Biol Markers 2006; 21: 190-198.
6. Melichar B, Cerman J, Malírová E. Successful management of infusion reaction accompanying the start of cetuximab therapy. Support Care Cancer 2007; 15: 445-449.
7. Farhadi A, Keshavarzian A, Holmes EW, Fields J, Zhang L, Banan A. Gas chromatographic method for detection of urinary sucralose: application to the assessment of intestinal permeability. Journal of Chromatogr B Analyt Technol Biomed Life Sci 2003; 784: 145-154.
8. Weiss G, Kronberger P, Conrad F, Bodner E, Wachter H, Reibnegger G. Neopterin and prognosis in patients with adenocarcinoma of the colon. Cancer Res 1993; 53: 260-265.
9. Melichar B, Hyspler R, Dragounova E, Dvorak J, Kalabova H, Ticha A. Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. BMC Cancer 2007; 7: 155. 23-27